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Objectives. This study aimed to characterize subcutaneous 
blood flow changes during neurally mediated syncope and to 
determine whether microvasculature oscillation (vasomotion) is 
characteristically altered in conjunction with syncopal events. 
Background. Marked pallor is commonly associated with neu- 
rally mediated syncope. However, little attention has been paid to 
the evaluation of subcutaneous blood flow and vasomotion i this 
setting. 
Methods. This study utilized laser Doppler flowmetry to assess 
changes in subcutaneous microvascular blood flow during 
head-up tilt table testing in 13 patients with syncope and 6 control 
subjects. Blood flow and vasomotion frequency were measured 
continuously before, during and after completion of 80 ° head-up 
tilt testing (<25-min duration). 
Results. Among the 13 patients with syncope, tilt testing 
reproduced syncopal symptoms in 9 (tilt-positive group) but not 
in 4 (tilt-negative group). None of the six control subjects devel- 
oped symptoms during testing. Baseline mean subcutaneous 
blood flow did not differ significantly among the three groups. 
However, during upright ilt, blood flow gradually diminished in 
the tilt-positive group, reaching a nadir of 0.8 -+ 0.33 ml/min per 
100 g of tissue (mean _+ SD), but remained relatively constant in 
the tilt-negative group and control subjects. The difference in 
mean blood flow response to tilt was statistically significant when 
the tilt-positive group was compared with either the tilt-negative 
group or control subjects (p < 0.001). Similarly, baseline blood 
flow oscillation frequency did not differ significantly in the three 
subgroups (tilt-positive group 0.2 -+ 0.11 Hz; tilt-negative group 
0.2 -+ 0.02 Hz; control subjects 0.2 -+ 0.11 Hz). Subsequently, 
during tilt testing only the tilt-positive group exhibited increased 
oscillation frequency; oscillation frequency remained essentially 
constant hroughout the tilt test in the tilt-negative group and 
control subjects (p < 0.001, tilt-positive group vs. either the 
tilt-negative group or control subjects). 
Conclusions. These findings document an expected iminution 
of subcutaneous blood flow in association with neurally mediated 
syncope and indicate that characteristic changes in microvascu- 
lature oscillation frequency occur in conjunction with syncopal 
symptoms. To the extent hat microvasculature vasomotion is 
influenced by neural control, the changes in vasomotion frequency 
are consistent with relative diminution of peripheral sympathetic 
neural influence during neurally mediated syncopal episodes. 
(J Am Coll Cardiol 1995;25:70-5) 
Vasomotor control of skin blood vessels is complex. Current 
understanding suggests that regional factors, such as local 
metabolic demand and temperature, exert greater influence on 
both rhythmic spontaneous changes in vessel diameter (vaso- 
motion) and the overall state of vasoconstriction itself than 
does central neural control (1). However, central sympathetic 
neural vasoconstrictor activity does appear to play an impor- 
tant role at times. For example, both mental and emotional 
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stress have been associated with increased sympathetic nerve 
activity to the skin (2) and may thereby be expected to 
modulate vasomotion. 
Although the common association of marked pallor with 
neurally mediated (vasovagal) syncope is well known, little 
attention has been paid to the evaluation of subcutaneous 
blood flow and vasomotion under these conditions. Conse- 
quently, the studies reported here were initiated to evaluate 
the evolution of subcutaneous blood flow during induced 
neurally mediated syncopal episodes and determine whether 
microvascular vasomotion is altered in a characteristic manner. 
To this end, we utilized laser Doppler flowmetry to compare 
patterns of subcutaneous blood flow in patients with and 
without neurally mediated syncope induced uring head-up tilt 
table testing (3-5). Measurements of relative blood flow 
change, vasomotor oscillation frequency and the amplitude of 
vasomotor activity were compared both in patients developing 
syncope during head-up tilt table testing and those who 
remained asymptomatic. 
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Figure 1. Schematic illustrating placement of the 
laser flow probe over the manubrium sterni in a 
supine patient, with an expansion fthe schematic 
indicating transmission f the laser signal toward 
the subcutaneous microvasculature. 
Methods  
Patients. Thirteen patients with recurrent syncope of un- 
known origin in whom tilt table testing was undertaken aspart 
of their diagnostic evaluation were included in this study (nine 
women, four men; 17 to 49 years old). Nine of these patients 
(mean [_+SD] age 30 -+ 12.1 years) ultimately developed 
syncope during the tilt procedure, whereas four (mean age 
36 +_ 6.2 years) remained asymptomatic. None of the patients 
had evidence of underlying structural heart disease by medical 
history, physical examination and echocardiographic evalua- 
tion. Additionally, none of the patients had been taking 
cardioactive medications before these studies. 
Control subjects. Six subjects (three women, three men; 
mean age 26 + 7 years) undergoing evaluation for supraven- 
tricular or ventricular ectopy, but without a history of syncope, 
were enrolled as control subjects. None had underlying struc- 
tural heart disease as assessed by physical examination and 
echocardiographic study, and all remained asymptomatic dur- 
ing head-up tilt. 
Tilt test protocol. The protocol utilized for tilt table testing 
in this laboratory has evolved with time (6,7). The following 
describes in brief the protocol used at the time these studies 
were undertaken. An intraarterial catheter (5F, generally 
within a femoral artery) was placed utilizing local anesthetic 
and was in position 45 to 60 rain (equilibration period) before 
initiation of upright tilt. During the equilibration period, 
patients and control subjects were allowed to rest in the supine 
position in a quiet laboratory before initiation of 80 ° upright 
tilt by means of an electronically controlled tilt table with 
footboard support. In the 13 patients with syncope, upright 
posture was maintained until development of syncope or for a 
maximal duration of 25 min, after which the patient was 
returned to the supine posture. In control subjects the maximal 
duration of the tilt test was 15 rain (i.e., approximately the 
mean time to syncope in patients with positive tilt test results 
plus 2 SD). Provocative pharmacologic measures, such as 
isoproterenol r edrophonium, were not utilized (7). In all 
cases, both electrocardiographic recordings and intraarterial 
blood pressure recordings were monitored continuously 
throughout the testing procedure. 
Subcutaneous blood perfusion monitoring. The laser 
Doppler blood perfusion monitor utilized in this study ("La- 
serflo" model BPM 403, TSI) incorporates a low power solid 
state infrared laser diode as a source of coherent light. An 
optical fiber delivers the light to the tissue. A probe head 
applied to the skin delivers a penetration of -1 mm 3 of tissue 
(Fig. 1). Available evidence suggests hat in this configuration, 
blood flow sampling is restricted to subcutaneous vessels and is 
unaffected by underlying muscle nutritive flow (3-5). 
As coherent light enters the tissue, photons are randomly 
scattered by both the moving red blood cells and the stationary 
tissue phase. Photons interacting with moving constituents are 
Doppler shifted and processed by a photodetector. Variables 
of frequency and power are analyzed to yield measurements of 
blood volume and blood speed. Each measurement is averaged 
over a time interval that can be set between 0.1 and 5.0 s. For 
purposes of this study the averaging time was 0.2 to 0.5 s, with 
the recording sensitivity set to provide a full-scale deflection of 
0 to 4.8 ml/min per 100 g of tissue. 
To obtain optimal blood flow recording despite the poten- 
tial for patient/subject movement during the tilt table proce- 
dure, the manubrium sterni was chosen for the recording site 
(Fig. 1). The recording equipment was connected to the 
patient after the skin was carefully cleaned and dried, and 
contact was effected by application of a small amount of 
coupling el. The probe and fiberoptic able were then secured 
using double-stick adhesive. Automatic internal testing en- 
sured proper linkage of the fiber optic cable to both the patient 
and the blood perfusion monitor. The stability of the recording 
site was verified in each study by asking the patient o take deep 
breaths. The latter maneuver also ensured that respiratory move- 
ment did not substantially influence the local recording. 
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Figure 2. Blood flow recordings illustrating the diminution ofoverall 
mean subcutaneous blood flow (MBF) and the net increase inblood 
flow oscillation frequency (note loss of superimposed slower frequen- 
cies) in a patient who developed syncope during head-up tilt table 
testing• In addition, the initial portion of the early recovery "over- 
shoot" is recorded at the far right. Ordinate indicates blood flow. 
action between these factors was examined to determine whether 
the groups had significantly different responses to tilt testing. 
Significant differences were followed by post hoc group compar- 
isons at each time point using the method of least significant 
differences with a Bonferroni correction for multiple compari- 
sons. A p value -<0.05 was considered statistically significant. 
Data analysis. Baseline recordings of subcutaneous blood 
flow, blood flow oscillation frequency and peak to peak 
amplitude of blood flow oscillation were averaged over a 5-min 
period just before initiation of upright ilt. However, because 
the period of upright ilt varied in duration among patients 
with syncope depending on whether symptoms developed and 
the time that syncope occurred, total duration of upright 
posture in each patient or subject was divided into quartiles. 
Measurements of blood flow, blood flow oscillation frequency 
and amplitude of oscillations were averaged over each quartile 
of tilt duration in each patient. After return of the patient o 
supine posture (recovery phase), findings were determined as 
averages of the first (early) and last (late) half of the posttest 
recording period. As a rule, continuous recordings were ob- 
tained for approximately the initial 5 min of the recovery 
period. Thus, "early" recovery encompassed approximately the 
first 2.5 min after return of the patient o the supine position. 
Given the slowest averaging time used in these studies for 
perfusion measurement (0.5 s, equivalent to a sampling rate of 
2 Hz), the worst case maximal detectable oscillation frequency 
was 1 Hz on the basis of the Nyquist rule. However, under 
normal conditions pontaneous rhythmic variations in human 
subcutaneous blood flow are reported to be <10 cycles/min (2 
SD above the mean), or 0.17 Hz (1). Therefore, the latter is 
well within the capabilities of the monitoring system. 
To analyze the principal frequency component of blood 
flow oscillation, a fast Fourier transform was obtained by 
digitally sampling the laser flow monitor output. Additionally, 
blood flow recordings were examined visually, and the princi- 
pal oscillation frequency was determined by manual measure- 
ment for confirmation. 
Statistical analysis. All results are reported as mean value 
_+ SD. Mean blood flow, oscillation frequency and oscillation 
amplitude were compared within one grouping factor (patients 
with tilt-positive results, patients with tilt-negative results, 
control subjects) and one repeated measure (time). The inter- 
Resu l ts  
Response of mean subcutaneous blood flow to head-up tilt 
table testing. Among the 13 patients included in this study, 
head-up tilt table testing was associated with development of 
syncope in 9 (tilt-positive group: 6 women, 3 men). The mean 
time to syncope was 5.9 + 4.4 rain (range 3.1 to 16). Figure 2 
illustrates blood flow recordings in one patient who developed 
syncope during head-up tilt testing. Figure 3 summarizes the 
effect of head-up tilt table testing on mean values of subcuta- 
neous blood flow for each stage of the study in the tilt-positive 
and tilt-negative groups and in control subjects. In the tilt- 
positive group, baseline subcutaneous mean blood flow was 
2.4 +_ 0.99 ml/min per 100 g of tissue. With immediate 
assumption of upright posture, mean blood flow was not 
significantly altered (2.44 + 1.01 ml/min per 100 g of tissue). 
However, a trend toward a diminution i  blood flow eventually 
became vident in these patients (Table 1). At the point at 
which syncope occurred, mean blood flow had substantially 
diminished (i.e., nadir of blood flow 0.8 _+ .33 ml/min per 100 g 
of tissue) from baseline (p < 0.02). In addition, the early phase 
of recovery after return to the supine position was character- 
ized by an abrupt increase in subcutaneous blood flow that 
exceeded baseline values in seven of nine patients (Fig. 3). 
Subsequently, blood flow returned to baseline but at variable 
times (often not for 10 to 15 rain). 
Among the four patients in whom syncope did not occur 
(tilt-negative group) and the six control subjects, baseline 
subcutaneous mean blood flow values did not differ signifi- 
cantly from those observed in the tilt-positive group (Table 1). 
However, in contradistinction to findings in the tilt-positive 
group, subcutaneous mean blood flow was essentially unaf- 
fected by upright posture in the tilt-negative group and control 
subjects and remained relatively constant hroughout the 
head-up tilt and the recovery periods. This response to tilt 
testing was statistically significantly different han that ob- 
served in the tilt-positive group (p < 0.001). 
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Table 1. Mean Subcutaneous Blood Flow, Oscillation Frequency and Oscillation Amplitude in Patients With Syncope and Control Subjects 
Tilt Quartile Recovery 
Baseline 1 2 3 4 Early Late 
Tilt-positive group (n - 9) 
MBF (ml/min per 100 g) 2,4 + 0.99 2.44 ± 1.0 2.3 _+ 1.0 2.2 ± 0.82 1.7 _+ 0.63 3.7 ± 0.81 2.0 _+ 0.89 
Osc frequency (Hz) 0.24 _+ 0.11 0.18 ± 0.08 0.16 + 0.06 0.24 ± 0.12 0.41 _+ 0.12 0.37 ± 0.15 0.21 ± 0.05 
Osc amplitude (ml/min per 8.6 -- 4.45 9.5 ± 3.56 7.3 _+ 2.64 7.1 + 3.31 4.5 ± 1.69 8.3 ± 3.59 8.8 _+ 3.17 
t00 g) 
Tilt-negative group (n - 4) 
MBF (ml/min per 100 g) 3.2 _+ 0.72 2.9 _+ 0.5 3.0 -+ 0.51 3.0 _+ 0.59 2.8 ± 0.57 3.15 ± 0.53 2.88 ± 0.50 
Osc frequency (Hz) 0.19 _+ 0.02 0.17 _+ 0.03 0.17 -- 0.03 0.16 +_ 0.02 0.17 ± 0.03 0.17 ± 0.02 0.18 ± 0.03 
Osc amplitude (ml/min per 7.5 _+ 2.27 6.1 _+ 2.78 7.0 +_ 2.38 6.1 ± 1.52 7.1 _+ 3.10 9.1 _+ 2.39 7.7 _+ 4.62 
100 g) 
Control subjects (n = 6) 
MBF (ml/min per 100 g) 2.8 _+ 0.1 2.7 _+ 0.11 2.8 _+ 0.20 2.9 -- 0.31 2.9 ± 0.11 3.0 ± 0.20 3.1 ± 0.21 
Osc frequency (Hz) 0.2 _+ 0.11 0.19 _+ 0.10 0.19 ± 0.10 0.2 _+ 0.09 0.2 ± 0.09 0.19 ± 0.09 0.2 ± 0.10 
Osc amplitude (ml/min per 7.8 _+ 3.0 7.0 _+ 2.9 7.0 _+ 2.5 7.0 _+ 2.2 7.5 ± 2.8 7.9 _+ 2.3 8.0 +_ 2.2 
100 g) 
Data presented are mean value _+SD. MBF = mean subcutaneous blood flow; Osc = oscillation. 
Response of blood flow oscillation frequency. Baseline 
principal subcutaneous blood flow oscillation frequency did 
not differ significantly among the three study groups (tilt- 
positive group 0.24 + 0.11 Hz, tilt-negative group 0.19 _+ 
0.02 Hz, control subjects 0.2 + 0.11 Hz). Additionally, both 
patients and control subjects tended to exhibit diminution of 
blood flow oscillation during the early phases (0% to 25% and 
25% to 50% of tilt duration [Table 1]). However, whereas the 
tilt-negative group and control subjects exhibited a relatively 
stable oscillation frequency throughout the remainder of the 
tilt test, those patients who ultimately developed syncope 
(tilt-positive group) tended to exhibit an increased oscillation 
frequency (Fig. 4). This inter group difference in response to 
tilt (Table 1) was statistically significant (p < 0.001). 
At the time of syncope (i.e., 100% of tilt duration) in the 
nine patients with positive tilt-table test results, the mean 
blood flow oscillation frequency was significantly greater than 
had been the case during the supine baseline stage (end-tilt 
frequency 0.41 _+ 0.12 Hz vs. baseline frequency 0.24 _+ 
0.11 Hz, p < 0.01). Typically, the change in oscillation fre- 
quency was relatively abrupt and occurred 78 _+ 30 s (range 39 
to 171 s) before syncope (note that precise timing of the latter 
is not possible). Analysis of differences among the groups 
during the course of the tilt test revealed that statistically 
significant differences became vident only in the last quartile 
of the tilt test (p < 0.01). 
During the supine recovery phase, patients who developed 
syncope during upright tilt exhibited gradual diminution of 
Figure 3. Comparison of mean values (+SD) of subcutaneous blood 
flow during head-up tilt testing in the tilt-positive and tilt-negative 
groups and control subjects. Note diminution of subcutaneous blood 
flow at time of syncope in the tilt-positive group, with subsequent 
"overshoot" during recovery. End-tilt valve depicts nadir of flow as 
opposed to average of 4th quartile in Table l. 
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Figure 4. Summary of changes in principal blood flow oscillation 
frequency in the tilt-positive and tilt-negative groups and control 
subjects. An increased oscillation frequency characterized the imme- 
diate presyncopal period in the tilt-positive group, with subsequent 
return to baseline during recovery. End-tilt valve depicts peak oscilla- 
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oscillation frequency. In the early recovery period, oscillation 
frequency did not differ substantially from that associated with 
the syncopal event. However, later during recovery (-5 min 
after the table returned to horizontal), the oscillation fre- 
quency had essentially returned to baseline value (late recov- 
ery 0.21 2 0.05 Hz vs. baseline 0.24 _+ 0.11 Hz). 
Amplitude variation of blood flow oscillations. Baseline 
peak to peak blood flow oscillation amplitude (ml/min per 
100 g of tissue) did not differ significantly in the three patient 
groups (tilt-positive group 8.6 2 4.45; tilt-negative group 7.5 2 
2.27; control subjects 7.8 2 3.0). Additionally, immediate 
assumption of upright posture did not substantially alter 
oscillation amplitude. However, the response to tilt differed 
between the tilt-positive group and the other two groups (p < 
0.02). Whereas oscillation amplitude in asymptomatic patients 
and control subjects tended to remain relatively constant, 
apparent diminution of oscillation amplitude was a character- 
istic finding in the tilt-positive group (Table 1). Statistically 
significant differences between the groups were principally due 
to findings in the last quartile of upright ilt (Table 1). 
Relation of subcutaneous blood flow to systemic arterial 
pressure. Among the four tilt-negative group patients and six 
control subjects, mean arterial pressure and subcutaneous mean 
blood flow remained relatively constant throughout the tilt test 
procedure. However, among the nine patients who developed 
syncope, diminution of mean blood flow appeared to parallel 
changes in mean arterial pressure. Compared with baseline 
values, syncope was associated with a reduction in mean blood 
flow and mean arterial pressure of 65% and 59%, respectively. 
Discuss ion  
Findings in this study reveal that subcutaneous blood flow 
measured by laser Doppler flowmetry exhibits characteristic 
changes in association with neurally mediated syncope induced 
during head-up tilt table testing. In particular, an increase in 
average blood flow oscillation frequency and reduction in 
oscillation amplitude occurred before development of symp- 
toms in those subjects who ultimately developed syncope 
during the study (tilt-positive group). To the extent that 
rhythmic oscillations of the microvasculature are influenced by 
ambient sympathetic neural tone (2), these findings are con- 
sistent with the view that peripheral sympathetic neural "with- 
drawal" occurs in close temporal proximity to neurally medi- 
ated syncopal events. Not unexpectedly, diminution of 
subcutaneous mean blood flow occurred progressively during 
upright ilt table testing in patients who developed syncope, 
with blood flow reduction particularly marked in close prox- 
imity to the syncopal event. In this regard, the ultimate 
magnitude of flow reduction closely paralleled the diminution 
of mean arterial pressure. Finally, among the tilt-positive 
group, the immediate resumption of the supine posture was 
associated with a marked overshoot of mean subcutaneous 
blood flow. In general, the early recovery period was associated 
with blood flows averaging 150% of baseline values. Subse- 
quently, baseline blood flow and blood flow oscillation fre- 
quency were restored (usually within 3 to 5 min but occasion- 
ally not until 10 to 15 min of the recovery phase). 
Subcutaneous microvascular vasomotion. Rhythmic mi- 
crovascular vasomotion has been described in a wide variety of 
experimental preparations. For example, Funk et al. (8) stud- 
ied spontaneous changes in vessel diameters of small arteries 
and arterioles in the hamster skin-fold preparation. Their 
findings indicated that as vessel diameter decreased, the fre- 
quency of spontaneous vasomotion tended to increase, with 
terminal arterioles exhibiting a frequency of 0.25 Hz (a value 
comparable to the baseline oscillation frequency measured in
this study, 0.2 2 0.10 Hz). In humans, laser Doppler flowmetry 
has been utilized to study rhythmic variations in microvascular 
blood flow. Salerud et al. (1) reported subcutaneous blood flow 
from the forehead and forearm in supine subjects. In some 
patients other sites were also evaluated. In essence, although 
there were regional differences, forehead microvascular blood 
flow oscillation ranged from 0.14 to 0.17 Hz and was thereby 
also similar to values obtained from the manubrium sterni 
region in the present study. The findings of Funk et al. (8) 
provided direct evidence in the hamster preparation of the 
presence of a background sympathetic neural vasoconstrictor 
tone in the arteriolar bed. The human appears to be similar in 
this regard. Delius et al. (2) recorded electrical activity from 
human skin nerves. In their study, sympathetic neural activity 
at rest consisted of irregular bursts of variable duration. 
Mental and emotional stress caused increased sympathetic 
nerve activity; however, postural change to a more vertical 
position did not appear to affect skin nerve activity (2). To the 
extent hat subcutaneous flow is controlled by sympathetic 
neural control, our findings are concordant with the latter 
observations because assumption ofupright posture had only a 
minor effect on mean blood flow values and blood flow 
oscillation frequency. 
Implications of altered blood flow oscillation frequency. 
Characterization f the frequency content of physiologic mea- 
surements has been of increasing interest. In particular, the 
dynamics of heart rate variability has been the subject of 
considerable study (9-13). In this setting, the highest fre- 
quency content (-0.15 to 0.40 Hz) is believed to be primarily 
related to parasympathetic effects, predominantly respiration. 
By contrast, frequencies in the range of 0.06 to 0.1 Hz appear 
to provide an index of sympathetic neural activity. Therefore, 
assuming that these spectral characteristics an be translated 
to the microvasculature, our findings uggest an initial modest 
increase in sympathetic neural constrictor tone early in the tilt 
(i.e., decreased principal oscillation frequency without substan- 
tial change in mean blood flow), followed by a diminution in 
sympathetic vasoconstrictor influence in temporal proximity to 
the syncopal event. The former is compatible with the elevated 
circulating catecholamine levels prevalent in the early phases 
of a vasovagal faint (14). Cutaneous sympathetic neural "with- 
drawal," on the other hand, is in contrast o a predicted 
increase in cutaneous sympathetic tone accompanying a vaso- 
vagal faint (15) and appears to occur later in close temporal 
relation to the faint. The latter would be expected to cause 
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arteriolar dilation and under normal circumstances might be 
associated with increased microvascular flow. However, given the 
concomitant diminished central cardiac output (resulting from 
bradycardia or reduced venous filling, or both, and shunting of 
blood to other dilated vascular beds), it is reasonable to assume 
that the subcutaneous microvasculature b comes hypoperfused in
the syncopal patient. Pallor would then be an expected outcome. 
Additionally, with return to the supine position, and the conse- 
quent recovery of cardiac output, an immediate and substantial 
"byperemic" response isunderstandable. 
The hyperemic response after transient reduction in skin 
blood flow circulation is a well recognized phenomenon. The 
mechanism is believed to be primarily local and dependent on 
physical and chemical changes associated with the recent loss of 
nutrient flow. However, central effects may modify the hyperemic 
response (16). In the present study, a hyperemic response was 
clearly demonstrated in the early recovery period (Fig. 2). Assess- 
ing the relation of the hyperemic response to the severity of 
diminished subcutaneous flow may be of interest but would 
require obtaining continuous flow recordings during the recovery 
period (to ascertain the area under the recovery curve until 
baseline was restored). These latter ecordings would need to be 
of extended uration to encompass the often prolonged recovery 
period and were not typically obtained in this study. 
Clinical implications. Recognition of the characteristic 
microvascular blood flow changes observed in this study (es- 
pecially oscillation frequency and amplitude) by monitoring 
subcutaneous blood flow may provide a tool for predicting the 
onset of neurally mediated syncopal events in susceptible 
subjects. In this regard there has been increasing interest in the 
potential application of implanted evices, such as pacemak- 
ers, for treatment of patients with recurrent refractory vasova- 
gal spells (17-19). However, recognition of treatable vents 
currently relies exclusively on development of marked brady- 
cardia. Because occurrence of sufficiently severe bradycardia s 
variable (both intrapatient and interpatient) and may occur 
relatively late in the episode (20), potentially useful interven- 
tions may be excessively delayed. Conceivably, the ability to 
monitor subcutaneous blood flow directly from the body of an 
implanted evice may provide a useful extravascular technique 
capable of assisting in the recognition of incipient neurally 
mediated hypotension bradycardia. 
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